SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10KSB - Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405]:
SEC Accession No. 0001116502-03-001225
Filing Date
2003-07-03
Accepted
2003-07-03 15:11:31
Documents
8
Period of Report
2003-01-31

Document Format Files

Seq Description Document Type Size
1 BIOSPECIFICS TECHNOLOGIES CORP. biospecifics10ksb.txt 10KSB 204350
3 AMENDMENT TO BYLAWS amendedbylaws-33.txt EX-3.3 1911
4 PROMISSORY NOTE FOR GELLER gellernote-1017.txt EX-10.17 23275
5 CONSENT OF BDO SEIDMAN, LLP auditorsconsent.txt EX-23.1 621
6 CERTIFICATION certification991.txt EX-99.1 1362
7 CERTIFICATION certification992.txt EX-99.2 1333
8 CERTIFICATION certification993.txt EX-99.3 3569
9 CERTIFICATION certification994.txt EX-99.4 3581
  Complete submission text file 0001116502-03-001225.txt   242378
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10KSB | Act: 34 | File No.: 000-19879 | Film No.: 03775249
SIC: 2834 Pharmaceutical Preparations